48,830
edits
Difference between revisions of "Salivary duct carcinoma"
Jump to navigation
Jump to search
m
→IHC
(twak) |
m (→IHC) |
||
| Line 76: | Line 76: | ||
*p63 -ve. | *p63 -ve. | ||
*Androgen receptor +ve. | *Androgen receptor +ve. | ||
*BRST2 (GCDFP-15) +ve. | *BRST2 ([[GCDFP-15]]) +ve. | ||
*HER2 +ve ~21%; use of [[trastuzumab]] (Herceptin) not systematically studied. | *HER2 +ve ~21%; use of [[trastuzumab]] (Herceptin) not systematically studied. | ||